if the IER is finished, and the directors know of the outcome, then how do they justify that they are complying with their continuous disclosure obligations?
can you think of ANYTHING more price sensitive than the determination of the fair value ascribed to the BOW sp?
anyone who is trading now in BOW shares are doing so in an ill-informed market.
even hiding the name of the IE is breaching the disclosure rule imho.
as usual, the s/h are treated like mushrooms.
cheers
- Forums
- ASX - By Stock
- BOW
- another 60c 3p stock valuation
another 60c 3p stock valuation, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOW (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online